• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mesoblast Ltd ADR (NQ: MESO )

    8.380 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Mesoblast Ltd ADR

    < Previous 1 2 3 4 5 6 Next >
    21 Stocks Moving in Wednesday's Pre-Market Session
    Gainers GBS Inc. (NASDAQ: GBS) rose 72.3% to $5.58 in pre-market trading. The company markets saliva test for diabetes management and previously announced collaboration on covid-... 
    Via Benzinga
    55 Biggest Movers From Yesterday
    Gainers Unico American Corporation (NASDAQ: UNAM) shares gained 59% to close at $4.15 on Tuesday. Elys Game Technology, Corp. (NASDAQ: ELYS) rose 43% to close at $6.62 after it... 
    Via Benzinga
    Why Mesoblast Stock Is Plunging After Q4 Earnings Report?
    Mesoblast Limited (NASDAQ: MESO) shares dived on Tuesday as the FDA raised more questions around its flagship drug candidate, and its annual loss widened. ... 
    Via Benzinga
    Exposures Product Safety
    33 Stocks Moving In Tuesday's Mid-Day Session
    Gainers AC Immune SA (NASDAQ: ACIU) shares jumped 68.4% to $11.77. AC Immune and its collaborating partner Genentech, part of Roche Holdings, announced topline data from Phase 2... 
    Via Benzinga
    Mesoblast (MESO) Q3 2021 Earnings Call Transcript
    MESO earnings call for the period ending June 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Mesoblast Shares 90-Day Survival Outcomes After Remestemcel-L From COVID-19 ARDS Trial
    Mesoblast Limited (NASDAQ: MESO) has announced the presentation of 90-day survival outcomes from the remestemcel-L trial in ventilator-dependent COVID-19 patients... 
    Via Benzinga
    Exposures COVID-19
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Gainers Alterity Therapeutics (NASDAQ:ATHE) shares moved upwards by 60.76% to $2.09 during Thursday's pre-market session. The market value of their outstanding shares... 
    Via Benzinga
    The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE... 
    Via Benzinga
    Exposures Product Safety
    Mesoblast Updates On Rexlemestrocel-L Program In Chronic Low Back Pain
    Mesoblast Limited (NASDAQ: MESO) provided an update on the strategy for bringing rexlemestrocel-L to patients in the U.S. with chronic low back pain (CLBP) due to... 
    Via Benzinga
    Mesoblast (MESO) Q3 2021 Earnings Call Transcript
    MESO earnings call for the period ending March 31, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2) BioCryst Pharmaceuticals,... 
    Via Benzinga
    The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
    Via Benzinga
    Exposures Product Safety
    The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
    Via Benzinga
    Exposures COVID-19
    Stocks That Hit 52-Week Lows On Tuesday
    Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    Friday's morning session saw 17 companies set new 52-week lows. Key Facts: Beyond Meat (NASDAQ:BYND) was the largest firm on a market cap basis to set a new 52-... 
    Via Benzinga
    The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
    Via Benzinga
    The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    55 Biggest Movers From Friday
    Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) jumped 45.5% to close at $49.80 on Friday after dropping around 22% on Thursday. Brooklyn ImmunoTherapeutics acquired... 
    Via Benzinga
    Why Mesoblast Limited Stock Is Jumping Today
    The company announced positive results from a clinical trial. 
    Via The Motley Fool
    Exposures COVID-19
    Mid-Afternoon Market Update: Dow Falls 200 Points; Cirrus Logic Shares Plunge
    Toward the end of trading Friday, the Dow traded down 0.60% to 33,856.90 while the NASDAQ fell 0.85% to 13,963.27. The S&P also fell, dropping 0.73% to 4,180.66. The U.S. has... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Mid-Day Market Update: Crude Oil Down 2.5%; CryoLife Shares Jump Following Q1 Results
    Midway through trading Friday, the Dow traded down 0.71% to 33,820.14 while the NASDAQ fell 0.44% to 14,020.26. The S&P also fell, dropping 0.64% to 4,184.44. The U.S. has the... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    38 Stocks Moving In Friday's Mid-Day Session
    Gainers Image Sensing Systems, Inc. (NASDAQ: ISNS) rose 29.2% to $5.93 after the company announced it initiated a quarterly dividend of $0.12 per share, authorized a 220,000... 
    Via Benzinga
    Mesoblast Shares Rise As Remestemcel-L Cuts Mortality In Patients Below 65 Years With COVID-19 Related Respiratory Distress
    Mesoblast Limited (NASDAQ: MESO) has announced 60-day results from the randomized controlled trial of remestemcel-L in COVID-19 patients with moderate/severe... 
    Via Benzinga
    Exposures COVID-19
    The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    Before 10 a.m. ET on Wednesday, 6 companies hit new 52-week lows. Noteables: The largest company by market cap to set a new 52-week low was Splunk (NASDAQ:SPLK).... 
    Via Benzinga
    The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... 
    Via Benzinga
    Exposures Product Safety
    38 Stocks Moving In Tuesday's Mid-Day Session
    Gainers RiceBran Technologies (NASDAQ: RIBT) shares jumped 60.8% to $1.4950. RiceBran Technologies is scheduled to host a conference call on April 28th to discuss its Q1... 
    Via Benzinga
    52 Biggest Movers From Yesterday
    Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 51.2% to close at $24.90 on Tuesday. Urban Tea, Inc. (NASDAQ: MYT) rose 38.1% to settle at $4.64. Vaxart, Inc. (... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    On Tuesday morning, 1 company achieved new low for the year. During the first half-hour of trading on Tuesday, the following stock reached new 52-week low... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.